Development and Effectiveness Evaluation of a Clustered Care Guideline Within Individualized Developmental Care: RCT
NCT ID: NCT07052786
Last Updated: 2025-09-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
44 participants
INTERVENTIONAL
2025-07-01
2025-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to develop a clustered care practice guideline and evaluate its effectiveness. The study was designed as a single-blind randomized controlled trial, where the participating nurses will not be informed about their group allocation (intervention or control) to reduce bias.The study will be conducted between July and September 2025 in the level 2 and 3 NICUs of Necmettin Erbakan University Faculty of Medicine Hospital in Konya, Turkey.
The study population includes all 44 nurses working in these NICUs who meet the inclusion criteria and agree to participate. Since the entire population is accessible, total population sampling will be used. After data collection is completed, a post hoc power analysis will be conducted using G\*Power (v3.1.9.2).
Data will be collected using the "Descriptive Information Form for the Infant and the Nurse" and the "Clustered Care Practice Guideline". Pre-test data will be collected before training, and post-test data will be collected 4-6 weeks after the training.
The intervention group will receive the Clustered Care Practice Training Based on Individualized Developmental Care in two in-person sessions (approx. 45 minutes per session), delivered in small groups (11-12 participants). A training booklet prepared by the researchers will be distributed at the end of the sessions.
The normality of the data will be assessed using the Kolmogorov-Smirnov test, normal distribution curves, and skewness-kurtosis values. Parametric tests will be used for normally distributed data; non-parametric tests will be used otherwise. A significance level of P\<0.05 will be applied.
Ethical approval was obtained from the Ethics Committee of KTO Karatay University Pharmaceutical and Medical Research (decision no: 2022/014, date: 21.06.2022). Institutional permission was obtained from NEU Faculty of Medicine Hospital. Written informed consent will be obtained from all participating nurses and from parents of the observed infants.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Home Support for Mothers Whose Premature Infants
NCT04741672
A Father-friendly Neonatal Intensive Care Unit
NCT05521620
Pilot Study: Effects of CCP Intervention on NICU Environment and Preterm Infants Development
NCT07306000
Effect Of Early Intervention Program Applied To Premature Infants
NCT06191757
Family Integrated Care in the NICU
NCT01852695
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This randomized controlled trial aims to evaluate the effectiveness of a clustered care practice guideline developed in accordance with individualized developmental care principles. The study will be conducted with nurses working in a neonatal intensive care unit. Nurses will be randomly assigned to either an intervention group or a control group.
The intervention group will receive training on the use of a clinical guideline designed to implement clustered care based on individualized developmental care, while the control group will continue to provide standard routine care. The effectiveness of the intervention will be assessed through the average scores obtained from the use of the guideline and a qualitative analysis of nurses' perspectives. This study is expected to highlight the importance of developmental care approaches in nursing and contribute to enhancing the overall quality of care provided in NICUs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
. The researcher will actively participate in the training and data collection process.
The ideal method is for the randomization list to be concealed from the researcher and nurses, and for the group to which each subject will belong to be disclosed to the researcher only after the participant has been included in the study by a person other than the researcher who has no direct role in the study. To prevent performance bias, nurses who met the inclusion criteria and provided informed consent were assigned to the study and control groups by an independent person according to the randomization list. This ensured the researcher's blinding. Since the researcher provided the training to the intervention group according to the guidelines, blinding of the practitioner was not possible. All participating nurses we
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
Individualized developmental care-based group care will be provided to infants according to the guidelines.
Infants will receive group care based on individualized developmental care according to the guide.
A guide to implementing group care based on individualized developmental care will be developed, and nurses working in the NICU will be trained in group care practices and how to use the guide.
Control group
Infants will receive routine care.
Standard care
Nurses working in the NICU will continue to provide standard care. After the study is completed, nurses in the control group will also receive the same training as the other group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Infants will receive group care based on individualized developmental care according to the guide.
A guide to implementing group care based on individualized developmental care will be developed, and nurses working in the NICU will be trained in group care practices and how to use the guide.
Standard care
Nurses working in the NICU will continue to provide standard care. After the study is completed, nurses in the control group will also receive the same training as the other group.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having at least 3 months of experience in the NICU,
* Volunteering to participate in the research.
Exclusion Criteria
* The nurse not participating in the training or not completing the training
* The nurse not being able to complete the study, including the final
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KTO Karatay University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fatma Tokan Özkılıçaslan
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emine Geçkil, MD, PhD
Role: STUDY_DIRECTOR
Necmettin Erbakan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Meram Faculty of Medicine
Konya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Meram Faculty of Medicine H Meram Faculty of Medicine, Hospital
Role: primary
hastane.erbakan.edu.tr
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022/014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.